ENTYVIO sous-cutanée 108 mg/0.68ml stylo prérempli
7680675340019
CH-67534
L04AG05
07.15.0.
Reimbursement limitations:
ENTYVIO2
Indiqué pour le traitement de la rectocolite hémorragique active modérée à sévère et de la …
1 / 2
google
Details
- Product number
- 6753401
- CPT
- -
- Packaging group
- 1
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- vedolizumabum 108 mg, acidum citricum monohydricum, natrii citras dihydricus corresp. natrium 1.11 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.68 ml.
Articles (1)
Entyvio subkutan 108 mg, Injektionslösung in einem Fertigpen
Injektionslösung in einem Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
108.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.11 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 608.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2021
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 67534
- Drug name
- Entyvio subkutan, Injektionslösung in einem Fertigpen
- Galenic form
- INLFP
- ATC Code
- L04AG05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 16/10/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ENTYVIO sous-cutanée 108 mg/0.68ml stylo prérempli
- Description (DE)
- ENTYVIO subkutan 108 mg/0.68ml Fertigpen
- Market launch
- 16/10/2020
- Narcotic (BTM)
- No